trial
as of 2026-07-01Positron Emission Tomography (PET) Imaging of Glial Activation in Psychotic Disease States
NCTId NCT03257592
at a glance
Phase 1 · Terminated
Enrollment 35 (actual)
Sponsored by Johns Hopkins University
Primary completion 2018-04
Synthesized from structured facts only — each point cited above.
Design & status
Phase
Phase 1
Status
Terminated
Enrollment
35 (actual)
Study type
Interventional
Allocation
Non Randomized
Model
Parallel
Masking
None
Start
2010-08
Primary completion
2018-04
Eligibility
ALL · 18 Years · 65 Years
Interventions & indications
Sponsors
Johns Hopkins UniversityLead Sponsor
Investigators
1
Martin Pomper, MD,PhDPrincipal Investigator
Sites
1 total
Baltimore, United States
Facts & assertions
4 sourced
Enrollment
35
Phase
PHASE1
Primary Completion Date
2018-04
Status
TERMINATED
relationships
The graph out of here
drug
drug
lead_sponsor
company
indication
investigator
person